Related Experiment Video

Updated: Mar 8, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K

The development of dendritic cell vaccine-based immunotherapies for glioblastoma

David A Reardon1, Duane A Mitchell2

  • 1Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Dana 2134, Boston, MA, 02215-5450, USA. David_Reardon@dfci.harvard.edu.

Seminars in Immunopathology
|February 1, 2017
PubMed

Insights

Dendritic cell vaccinations show promise for treating cancer, particularly glioblastoma. Emerging data highlight their biologic advantages and therapeutic potential in preclinical and clinical settings.

Area of Science:

  • Immunology
  • Oncology
  • Neuro-oncology

Background:

  • Glioblastoma is an aggressive brain tumor with limited treatment options.
  • Dendritic cell (DC)-based vaccines are an immunotherapy approach.
  • Understanding DC vaccine biology is crucial for cancer therapy.

Purpose of the Study:

  • To review the biologic advantages of dendritic cell-based vaccinations for cancer therapy.
  • To summarize preclinical and clinical data for glioblastoma patients.

Main Methods:

  • Literature review of dendritic cell vaccination strategies.
  • Analysis of preclinical studies in glioblastoma models.
  • Evaluation of emerging clinical trial data.

Main Results:

  • Dendritic cells present tumor antigens to activate anti-tumor immune responses.
  • Preclinical data suggest DC vaccines can enhance immune surveillance against glioblastoma.
  • Early clinical data indicate potential safety and efficacy of DC vaccines in glioblastoma.

Conclusions:

  • Dendritic cell-based vaccines offer a promising therapeutic avenue for glioblastoma.
  • Further clinical investigation is warranted to optimize DC vaccine strategies.
  • DC vaccines represent a key area of research in immuno-oncology for brain tumors.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K